Home > Drug Search >
  • company_query: Boston Biomedical
  •   > 
Drug Filter
Category:
chemistry (30) biology (8)
Status:
Approved (6) BLA Filing (2) Phase Ⅲ (6) Phase Ⅱ (11) Phase Ⅰ (13)
Clinical Stage:
Pending (3) Active (12) Discontinued (17)
Bio-Type:
Recombinant cytokines (3) Whole antibody (4) Fusion protein (1)
Indication:
Alzheimer's disease (AD) (1) Angina pectoris (1) Anxiety (1) Arrhythmia (1) Atherosclerosis (1) Atopic dermatitis (1) Basal cell carcinoma (BCC) (1) Breast cancer (2) Cancer chemotherapy (1) Chronic lymphocytic leukemia (CLL) (1) Colorectal neoplasms (1) Crohn's disease (1) Common warts (1) Follicular lymphoma (1) Gastric cancer (1) Generalised anxiety disorder (GAD) (1) HBV infection (1) Heart failure (1) HIV infection (1) Hyperlipidemia (1) Major depressive disorder (MDD) (1) Malignancies (1) Migraine (1) Multiple sclerosis (MS) (2) Leucopenia (1) Neuropathic pain (1) Non-Hodgkin’s lymphoma (NHL) (1) Obesity (1) Osteoarthritis (OA) (1) Ovarian cancer (1) Pancreatic cancer (1) Postoperative pain (1) Psoriatic arthritis (1) Rheumatoid arthritis (RA) (7) Small cell lung cancer (SCLC) (1) Solid tumours (4) Type 2 diabetes (1) Ankylosing Spondylitis (AS) (1) Cirrhosis (1) Microscopic polyangiitis (1) Granulomatosis with polyangiitis (1) Spondyloarthritis (1) Neutropenia (2) Plaque psoriasis (2) Diffuse large B cell lymphoma (1) Bacterial infection (1) Psychiatric disorders (2) hematological malignancies (1) Inflammatory pain (1) Juvenile idiopathic arthritis (JIA) (1)
Country:
Aprv. Year:
2004 (1) 2009 (1) 2016 (1) 2017 (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top